Use of the transforming growth factor-β1 inhibitor peptide in periprosthetic capsular fibrosis: Experimental model with tetraglycerol dipalmitate

Plastic and Reconstructive Surgery

Volumn 116, Issue 5, 2005, Pages 1370-1378

  Ruiz De Erenchun, Richard ^a,b,c   Dotor De Las Herrerias J ^a,b   Hontanilla, B ^a,b  

^a Universidad de Navarra ^*

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCEROL DERIVATIVE; PALMITIC ACID DERIVATIVE; TETRAGLYCEROL DIPALMITATE; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FIBROSIS; IMMUNE RESPONSE; INFLAMMATION; JOINT CAPSULE; JOINT PROSTHESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SCAR FORMATION; SILICONE PROSTHESIS; WOUND CONTRACTION;

ANIMALS; CONTRACTURE; FEMALE; FIBROSIS; PEPTIDE FRAGMENTS; PROSTHESES AND IMPLANTS; RATS; RATS, WISTAR; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;

EID: 26844488099     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000181694.07661.0d     Document Type: Article

References (34)

1. Georgiade, N., Georgiade, G., and Riefkohl, R. Aesthetic breast surgery. In J. C. McCarthy (Ed.), Plastic Surgery. Philadelphia: Saunders, 1990. P. 3886.
2. Mazaheri, M. K., Schultz, G. S., Blalock, T. D., Caffee, H. H., and Chin, G. A. Role of connective tissue growth factor in breast implant elastomer capsular formation. Ann. Plast. Surg. 50: 263, 2003.
3. Ersek, R. A. Firestorm fibrosis: The fast fibrotic phenomenon. Ann. Plast. Surg. 26: 494, 1991.
4. Wyatt, L. E., Sinow, J. D., Wollman, J. S., Sami, D. A., and Miller, T. A. The influence of time on human breast capsule histology: Smooth and textured silicone-surfaced implants. Plast. Reconstr. Surg. 102: 1922, 1998.
5. Milojevic, B. Unilateral fibrous contracture in augmentation mammaplasty. Aesthetic Plast. Surg. 7: 117, 1983.
6. Dobke, M. K., Svanhn, J. K., Vastine, V. L., Landon, B. N., Stein, P. C., and Parson, C. L. Characterization of microbial presence at the surface of silicone mammary implants. Ann. Plast. Surg. 34: 563, 1995.
7. Caffee, H. H. The influence of silicone bleed on capsule contracture. Ann. Plast. Surg. 17: 284, 1986.
8. Embrey, M., Adams, E. E., Cunningham, B., et al. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast. Surg. 23: 197, 1999.
9. Hipps, C. J., Raju, R., and Straith, R. E. Influence of some operative and postoperative factors on capsular contracture around breast prostheses. Plast. Reconstr. Surg. 61: 384, 1978.
10. Shah, M., Rorison, P., and Ferguson, M. W. J. The role of transforming growth factors-beta in cutaneous scarring. In M. T. Longaker (Ed.), Scarless Wound Healing. New York: Marcel Dekker, 2000. P. 213.
11. Kuhn, A., Singh, S., Smith, P. D., et al. Periprosthetic breast capsules contain the fibrogenic cytokines TGF-beta1 and TGF-beta2, suggesting possible new treatment approaches. Ann. Plast. Surg. 44: 387, 2000.
12. Shah, M., Foreman, D. M., and Ferguson, M. W. Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. J. Cell Sci. 108 (Pt. 3): 985, 1995.
13. Shah, M., Foreman, D. M., and Ferguson, M. W. Neutralising antibody to TGF-beta 1,2 reduces cutaneous scarring in adult rodents. J. Cell Sci. 107 (Pt. 5): 1137, 1994.
14. Tredget, E. E., Shankowsky, H. A., Pannu, R., et al. Transforming growth factor-beta in thermally injured patients with hypertrophic scars: Effects of interferon alpha-2b. Plast. Reconstr. Surg. 102: 1317, 1998.
15. Ezquerro, I.J., Lasarte, J. J., Dotor, J., et al. A synthetic peptide from transforming growth factor B type III receptor inhibits liver fibrogenesis in rats with carbon tetrachloride liver injury. Cytokine 22: 12, 2003.
16. Yamagata, Y., Yuasa, Y., Yamamoto, K., et al. Pharmacologic effect of recombinant human IFN-alpha, continuously released from a matrix prepared from a polyglycerol ester of fatty acids, on 2′,5′-oligoadenylate synthetase activity in murine liver. J. Interferon Cytokine Res. 20: 153, 2000.
17. Caffee, H. H. Capsule injection for the prevention of contracture. Plast. Reconstr. Surg. 110: 1325, 2002.
18. Ajmal, N., Riordan, C. L., Cardwell, N., Nanney, L. B., and Shack, R. B. The effectiveness of sodium 2-mercaptoethane sulfonate (mesna) in reducing capsular formation around implants in a rabbit model. Plast. Reconstr. Surg. 112: 1455, 2003.
19. Lemperle, G., and Exner, K. Effect of cortisone on capsular contracture in double-lumen breast implants: Ten years' experience. Aesthetic Plast. Surg. 17: 317, 1993.
20. Baker, J. L. The effectiveness of alpha-tocopherol (vitamin E) in reducing the incidence of spherical contracture around breast implants. Plast. Reconstr. Surg. 68: 696, 1981.
21. Choi, B. M., Kwak, H. J., Jun, C. D., et al. Control of scarring in adult wounds using antisense transforming growth factor-beta 1 oligodeoxynucleotides. Immunol. Cell Biol. 74: 144, 1996.
22. Yang, L., Tredget, E. E., and Ghahary, A. Activation of latent transforming growth factor-beta1 is induced by mannose 6-phosphate/insulin-like growth factor-II receptor. Wound Repair Regen. 8: 538, 2000.
23. Nunes, I., Gleizes, P. E., Metz, C. N., and Rifkin, D. B. Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J. Cell Biol. 136: 1151, 1997.
24. Carter, D. Tissue reaction to breast implants. Am. J. Clin. Pathol. 102: 565, 1994.
25. Smahel, J. Histology of the capsules causing constrictive fibrosis around breast implants. Br. J. Plast. Surg. 30: 324, 1977.
26. Smahel, J., Hurwitz, P. J., and Hurwitz, N. Soft-tissue response to textured silicone implants in an animal experiment. Plast. Reconstr. Surg. 92: 474, 1993.
27. Bucky, L. P., Ehrlich, H. P., Sohoni, S., and May, J. W. The capsule quality of saline-filled smooth silicone, textured silicone, and polyurethane implants in rabbits: A long-term study. Plast. Reconstr. Surg. 93: 1123, 1994.
28. Hakelius, L., and Ohlsen, L. Tendency to capsular contracture around smooth and textured gel-filled silicone mammary implants: A five-year follow-up. Plast. Reconstr. Surg. 100: 1566, 1997.
29. Asplund, O., Gylbert, L., Jurell, G., and Ward, C. Textured or smooth implants for submuscular breast augmentation: A controlled study. Plast. Reconstr. Surg. 97: 1200, 1996.
30. Clugston, P. A., Perry, L. C., Hammond, D. C., and Maxwell, G. P. A rat model for capsular contracture: The effects of surface texturing. Ann. Plast. Surg. 33: 595, 1994.
31. Piscatelli, S. J., Partington, M., Hobar, C., Gregory, P., and Siebert, J. W. Breast capsule contracture: Is fibroblast activity associated with severity? Aesthetic Plast. Surg. 18: 75, 1994.
32. Carpaneda, C. A. Inflammatory reaction and capsular contracture around smooth silicone implants. Aesthetic Plast. Surg. 21: 110, 1997.
33. Siggelkow, W., Faridi, A., Spiritus, K., et al. Histological analysis of silicone breast implant capsules and correlation with capsular contracture. Biomaterials 24: 1101, 2003.
34. Shah, M., Foreman, D. M., and Ferguson, M. W. Control of scarring in adult wounds by neutralising antibody to transforming growth factor beta. Lancet 339: 213, 1992.